JD

Jyoti Dubey

Active Director Director DIN 09217403
DIN 09217403 First appointment Jun 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value •••• Premium profile

About Jyoti Dubey

Data last updated:

Jyoti Dubey is a Director at Oparin Biotech Private Limited (since 2021). The company operates in Healthcare. Oparin Biotech Private Limited reported revenue of ₹65,891 (FY 2023).

DIN 09217403
Primary Designation Director
Industry Healthcare
First Appointment 04 Jun 2021
Oldest Company Age 11 yrs
Largest company Oparin Biotech Private Limited · ₹65,891 (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oparin Biotech Private Limited U85191UP2015PTC069475
Director04 Jun 20212015₹65,891 (FY 2023)Active

Board colleagues of Jyoti Dubey

NameDINCompanyDesignation
Pramod Kumar Dubey07056040Oparin Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oparin Biotech Private Limited
Premium access

Shareholding and investment profile for Jyoti Dubey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Dubey

Jyoti Dubey currently holds 1 directorship: Oparin Biotech Private Limited (Director, since 04 Jun 2021, revenue ₹65,891 (FY 2023)).

Jyoti Dubey was first appointed on 04 Jun 2021 as Director at Oparin Biotech Private Limited.

The current boards of Jyoti Dubey's companies include Pramod Kumar Dubey (Oparin Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available